5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate

C250H257B3F11N55O13 — CID 163920941

IUPAC5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate
SMILESC.C.C.C.C.C.C.C.C.C.C.C.CC1(C)OB(O)c2ccc(-c3nc4ccc5[nH]ncc5c4c4c3CCCC4)cc21.CC1=NCc2ccc(-c3nc4ccc5n[nH]c(C)c5c4c4c3CCCC4)cc21.COc1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)cc1B(O)O.Cc1[nH]ncc1-c1nc2ccc3n[nH]c(C)c3c2c2c1CC(N)CC2.Cc1[nH]ncc1-c1nc2ccc3n[nH]c(C)c3c2c2c1CCCC2.Cc1[nH]ncc1-c1nc2ccc3n[nH]c(CO)c3c2c2c1CCCC2.Fc1cc2[nH]ncc2c2c3c(c(-c4cn[nH]c4)nc12)CCCC3.O=C1c2ccccc2C(=O)N1Cc1[nH]ncc1-c1nc2ccc3[nH]ncc3c2c2c1CCCC2.O=COc1cc(-c2cn[nH]c2C(F)(F)F)nc2ccc3[nH]ncc3c12.OB(O)c1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)o1.[2H]C1([2H])Cc2c(c(-c3cn[nH]c3C(F)(F)F)nc3c(F)cc4[nH]ncc4c23)C([2H])([2H])C1([2H])[2H].[2H]C1([2H])Cc2c(c(-c3cn[nH]c3C(F)(F)F)nc3ccc4n[nH]c(C)c4c23)C([2H])([2H])C1([2H])[2H]
InChIInChI=1S/C26H20N6O2.C24H22N4.C23H22BN3O2.C21H20BN3O3.C19H16F3N5.C19H20N6.C19H19N5O.C19H19N5.C18H16BN3O3.C18H13F4N5.C17H14FN5.C15H8F3N5O2.12CH4/c33-25-16-7-3-4-8-17(16)26(34)32(25)13-22-19(12-28-31-22)24-15-6-2-1-5-14(15)23-18-11-27-30-20(18)9-10-21(23)29-24;1-13-19-11-15(7-8-16(19)12-25-13)24-18-6-4-3-5-17(18)23-20(26-24)9-10-21-22(23)14(2)27-28-21;1-23(2)17-11-13(7-8-18(17)24(28)29-23)22-15-6-4-3-5-14(15)21-16-12-25-27-19(16)9-10-20(21)26-22;1-28-19-9-6-12(10-16(19)22(26)27)21-14-5-3-2-4-13(14)20-15-11-23-25-17(15)7-8-18(20)24-21;1-9-15-14(26-25-9)7-6-13-16(15)10-4-2-3-5-11(10)17(24-13)12-8-23-27-18(12)19(20,21)22;1-9-14(8-21-23-9)19-13-7-11(20)3-4-12(13)18-15(22-19)5-6-16-17(18)10(2)24-25-16;1-10-13(8-20-22-10)19-12-5-3-2-4-11(12)17-14(21-19)6-7-15-18(17)16(9-25)24-23-15;1-10-14(9-20-22-10)19-13-6-4-3-5-12(13)18-15(21-19)7-8-16-17(18)11(2)23-24-16;23-19(24)16-8-7-15(25-16)18-11-4-2-1-3-10(11)17-12-9-20-22-13(12)5-6-14(17)21-18;19-12-5-13-10(6-23-26-13)14-8-3-1-2-4-9(8)15(25-16(12)14)11-7-24-27-17(11)18(20,21)22;18-13-5-14-12(8-21-23-14)15-10-3-1-2-4-11(10)16(22-17(13)15)9-6-19-20-7-9;16-15(17,18)14-8(5-20-23-14)11-3-12(25-6-24)13-7-4-19-22-9(7)1-2-10(13)21-11;;;;;;;;;;;;/h3-4,7-12H,1-2,5-6,13H2,(H,27,30)(H,28,31);7-11H,3-6,12H2,1-2H3,(H,27,28);7-12,28H,3-6H2,1-2H3,(H,25,27);6-11,26-27H,2-5H2,1H3,(H,23,25);6-8H,2-5H2,1H3,(H,23,27)(H,25,26);5-6,8,11H,3-4,7,20H2,1-2H3,(H,21,23)(H,24,25);6-8,25H,2-5,9H2,1H3,(H,20,22)(H,23,24);7-9H,3-6H2,1-2H3,(H,20,22)(H,23,24);5-9,23-24H,1-4H2,(H,20,22);5-7H,1-4H2,(H,23,26)(H,24,27);5-8H,1-4H2,(H,19,20)(H,21,23);1-6H,(H,19,22)(H,20,23);12*1H4/i;;;;2D2,3D2,5D2;;;;;1D2,2D2,4D2;;;;;;;;;;;;;;
InChIKeyRAIUYEUEJNMYQF-GGDJXXHOSA-N
MW4493.67 g/mol
LogP50.91
Rot. Bonds20

About 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate

5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate (PubChem CID 163920941) has the molecular formula C250H257B3F11N55O13 and a molecular weight of 4493.67 g/mol. Its IUPAC name is 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate.

Molecular Properties

Compound Name5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate
PubChem CID163920941
Molecular FormulaC250H257B3F11N55O13
Molecular Weight4493.67 g/mol
Exact Mass4491.20
IUPAC Name5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate
SMILESC.C.C.C.C.C.C.C.C.C.C.C.CC1(C)OB(O)c2ccc(-c3nc4ccc5[nH]ncc5c4c4c3CCCC4)cc21.CC1=NCc2ccc(-c3nc4ccc5n[nH]c(C)c5c4c4c3CCCC4)cc21.COc1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)cc1B(O)O.Cc1[nH]ncc1-c1nc2ccc3n[nH]c(C)c3c2c2c1CC(N)CC2.Cc1[nH]ncc1-c1nc2ccc3n[nH]c(C)c3c2c2c1CCCC2.Cc1[nH]ncc1-c1nc2ccc3n[nH]c(CO)c3c2c2c1CCCC2.Fc1cc2[nH]ncc2c2c3c(c(-c4cn[nH]c4)nc12)CCCC3.O=C1c2ccccc2C(=O)N1Cc1[nH]ncc1-c1nc2ccc3[nH]ncc3c2c2c1CCCC2.O=COc1cc(-c2cn[nH]c2C(F)(F)F)nc2ccc3[nH]ncc3c12.OB(O)c1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)o1.[2H]C1([2H])Cc2c(c(-c3cn[nH]c3C(F)(F)F)nc3c(F)cc4[nH]ncc4c23)C([2H])([2H])C1([2H])[2H].[2H]C1([2H])Cc2c(c(-c3cn[nH]c3C(F)(F)F)nc3ccc4n[nH]c(C)c4c23)C([2H])([2H])C1([2H])[2H]
InChIInChI=1S/C26H20N6O2.C24H22N4.C23H22BN3O2.C21H20BN3O3.C19H16F3N5.C19H20N6.C19H19N5O.C19H19N5.C18H16BN3O3.C18H13F4N5.C17H14FN5.C15H8F3N5O2.12CH4/c33-25-16-7-3-4-8-17(16)26(34)32(25)13-22-19(12-28-31-22)24-15-6-2-1-5-14(15)23-18-11-27-30-20(18)9-10-21(23)29-24;1-13-19-11-15(7-8-16(19)12-25-13)24-18-6-4-3-5-17(18)23-20(26-24)9-10-21-22(23)14(2)27-28-21;1-23(2)17-11-13(7-8-18(17)24(28)29-23)22-15-6-4-3-5-14(15)21-16-12-25-27-19(16)9-10-20(21)26-22;1-28-19-9-6-12(10-16(19)22(26)27)21-14-5-3-2-4-13(14)20-15-11-23-25-17(15)7-8-18(20)24-21;1-9-15-14(26-25-9)7-6-13-16(15)10-4-2-3-5-11(10)17(24-13)12-8-23-27-18(12)19(20,21)22;1-9-14(8-21-23-9)19-13-7-11(20)3-4-12(13)18-15(22-19)5-6-16-17(18)10(2)24-25-16;1-10-13(8-20-22-10)19-12-5-3-2-4-11(12)17-14(21-19)6-7-15-18(17)16(9-25)24-23-15;1-10-14(9-20-22-10)19-13-6-4-3-5-12(13)18-15(21-19)7-8-16-17(18)11(2)23-24-16;23-19(24)16-8-7-15(25-16)18-11-4-2-1-3-10(11)17-12-9-20-22-13(12)5-6-14(17)21-18;19-12-5-13-10(6-23-26-13)14-8-3-1-2-4-9(8)15(25-16(12)14)11-7-24-27-17(11)18(20,21)22;18-13-5-14-12(8-21-23-14)15-10-3-1-2-4-11(10)16(22-17(13)15)9-6-19-20-7-9;16-15(17,18)14-8(5-20-23-14)11-3-12(25-6-24)13-7-4-19-22-9(7)1-2-10(13)21-11;;;;;;;;;;;;/h3-4,7-12H,1-2,5-6,13H2,(H,27,30)(H,28,31);7-11H,3-6,12H2,1-2H3,(H,27,28);7-12,28H,3-6H2,1-2H3,(H,25,27);6-11,26-27H,2-5H2,1H3,(H,23,25);6-8H,2-5H2,1H3,(H,23,27)(H,25,26);5-6,8,11H,3-4,7,20H2,1-2H3,(H,21,23)(H,24,25);6-8,25H,2-5,9H2,1H3,(H,20,22)(H,23,24);7-9H,3-6H2,1-2H3,(H,20,22)(H,23,24);5-9,23-24H,1-4H2,(H,20,22);5-7H,1-4H2,(H,23,26)(H,24,27);5-8H,1-4H2,(H,19,20)(H,21,23);1-6H,(H,19,22)(H,20,23);12*1H4/i;;;;2D2,3D2,5D2;;;;;1D2,2D2,4D2;;;;;;;;;;;;;;
InChIKeyRAIUYEUEJNMYQF-GGDJXXHOSA-N
XLogP50.91
TPSA983.32 Ų
H-Bond Donors27
H-Bond Acceptors47
Rotatable Bonds20
Heavy Atoms332
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5004493.67
LogP ≤ 550.91
H-Bond Donors ≤ 527
H-Bond Acceptors ≤ 1047

Analyze 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate?
The IUPAC name of 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate (CID 163920941) is 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate.
What is the SMILES notation for 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate?
The canonical SMILES for 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate is C.C.C.C.C.C.C.C.C.C.C.C.CC1(C)OB(O)c2ccc(-c3nc4ccc5[nH]ncc5c4c4c3CCCC4)cc21.CC1=NCc2ccc(-c3nc4ccc5n[nH]c(C)c5c4c4c3CCCC4)cc21.COc1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)cc1B(O)O.Cc1[nH]ncc1-c1nc2ccc3n[nH]c(C)c3c2c2c1CC(N)CC2.Cc1[nH]ncc1-c1nc2ccc3n[nH]c(C)c3c2c2c1CCCC2.Cc1[nH]ncc1-c1nc2ccc3n[nH]c(CO)c3c2c2c1CCCC2.Fc1cc2[nH]ncc2c2c3c(c(-c4cn[nH]c4)nc12)CCCC3.O=C1c2ccccc2C(=O)N1Cc1[nH]ncc1-c1nc2ccc3[nH]ncc3c2c2c1CCCC2.O=COc1cc(-c2cn[nH]c2C(F)(F)F)nc2ccc3[nH]ncc3c12.OB(O)c1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)o1.[2H]C1([2H])Cc2c(c(-c3cn[nH]c3C(F)(F)F)nc3c(F)cc4[nH]ncc4c23)C([2H])([2H])C1([2H])[2H].[2H]C1([2H])Cc2c(c(-c3cn[nH]c3C(F)(F)F)nc3ccc4n[nH]c(C)c4c23)C([2H])([2H])C1([2H])[2H].
What is the InChIKey of 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate?
The InChIKey is RAIUYEUEJNMYQF-GGDJXXHOSA-N. The full InChI is InChI=1S/C26H20N6O2.C24H22N4.C23H22BN3O2.C21H20BN3O3.C19H16F3N5.C19H20N6.C19H19N5O.C19H19N5.C18H16BN3O3.C18H13F4N5.C17H14FN5.C15H8F3N5O2.12CH4/c33-25-16-7-3-4-8-17(16)26(34)32(25)13-22-19(12-28-31-22)24-15-6-2-1-5-14(15)23-18-11-27-30-20(18)9-10-21(23)29-24;1-13-19-11-15(7-8-16(19)12-25-13)24-18-6-4-3-5-17(18)23-20(26-24)9-10-21-22(23)14(2)27-28-21;1-23(2)17-11-13(7-8-18(17)24(28)29-23)22-15-6-4-3-5-14(15)21-16-12-25-27-19(16)9-10-20(21)26-22;1-28-19-9-6-12(10-16(19)22(26)27)21-14-5-3-2-4-13(14)20-15-11-23-25-17(15)7-8-18(20)24-21;1-9-15-14(26-25-9)7-6-13-16(15)10-4-2-3-5-11(10)17(24-13)12-8-23-27-18(12)19(20,21)22;1-9-14(8-21-23-9)19-13-7-11(20)3-4-12(13)18-15(22-19)5-6-16-17(18)10(2)24-25-16;1-10-13(8-20-22-10)19-12-5-3-2-4-11(12)17-14(21-19)6-7-15-18(17)16(9-25)24-23-15;1-10-14(9-20-22-10)19-13-6-4-3-5-12(13)18-15(21-19)7-8-16-17(18)11(2)23-24-16;23-19(24)16-8-7-15(25-16)18-11-4-2-1-3-10(11)17-12-9-20-22-13(12)5-6-14(17)21-18;19-12-5-13-10(6-23-26-13)14-8-3-1-2-4-9(8)15(25-16(12)14)11-7-24-27-17(11)18(20,21)22;18-13-5-14-12(8-21-23-14)15-10-3-1-2-4-11(10)16(22-17(13)15)9-6-19-20-7-9;16-15(17,18)14-8(5-20-23-14)11-3-12(25-6-24)13-7-4-19-22-9(7)1-2-10(13)21-11;;;;;;;;;;;;/h3-4,7-12H,1-2,5-6,13H2,(H,27,30)(H,28,31);7-11H,3-6,12H2,1-2H3,(H,27,28);7-12,28H,3-6H2,1-2H3,(H,25,27);6-11,26-27H,2-5H2,1H3,(H,23,25);6-8H,2-5H2,1H3,(H,23,27)(H,25,26);5-6,8,11H,3-4,7,20H2,1-2H3,(H,21,23)(H,24,25);6-8,25H,2-5,9H2,1H3,(H,20,22)(H,23,24);7-9H,3-6H2,1-2H3,(H,20,22)(H,23,24);5-9,23-24H,1-4H2,(H,20,22);5-7H,1-4H2,(H,23,26)(H,24,27);5-8H,1-4H2,(H,19,20)(H,21,23);1-6H,(H,19,22)(H,20,23);12*1H4/i;;;;2D2,3D2,5D2;;;;;1D2,2D2,4D2;;;;;;;;;;;;;;.
What are the key properties of 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate?
5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate has a molecular weight of 4493.67 g/mol, XLogP of 50.91, 20 rotatable bonds, 27 hydrogen bond donors, and 47 hydrogen bond acceptors.
Where does this data come from?
All data for 5-fluoro-7-(1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-5-fluoro-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3,11-dihydropyrazolo[4,3-a]phenanthridine;8,8,9,9,10,10-hexadeuterio-1-methyl-7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-2,11-dihydropyrazolo[4,3-a]phenanthridine;7-(1-hydroxy-3,3-dimethyl-2,1-benzoxaborol-5-yl)-8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridine;methane;[2-methoxy-5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]boronic acid;1-methyl-7-(3-methyl-1H-isoindol-5-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-9-amine;1-methyl-7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridine;[7-(5-methyl-1H-pyrazol-4-yl)-8,9,10,11-tetrahydro-2H-pyrazolo[4,3-a]phenanthridin-1-yl]methanol;[5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)furan-2-yl]boronic acid;2-[[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)-1H-pyrazol-5-yl]methyl]isoindole-1,3-dione;[7-[5-(trifluoromethyl)-1H-pyrazol-4-yl]-3H-pyrazolo[4,5-f]quinolin-9-yl] formate is sourced from PubChem (CID 163920941), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).